Bayer has to be liable for the cancer of two plaintiffs – a US court confirms this. In 2018, the Dax group bought the seed giant Monsanto and thus brought several legal disputes into the house.
The agrochemical and pharmaceutical company Bayer has also received a defeat in the third of its US appeal proceedings because of alleged cancer risks of the weed killer glyphosate. The competent court in San Francisco upheld a ruling that Bayer is liable for cancers suffered by plaintiffs Alberta and Alva Pilliod.
A jury in California first sentenced the group in 2019 to damages and fines of around two billion dollars to the couple. The court later reduced the amount to $ 86.7 million.
A spokesman for Bayer said the company respected the court’s decision, but disagreed with it. The judgment is not supported by the evidence at the trial or by applicable law. The group is exploring its options for a re-examination of the case.
Bayer had this and many other legal conflicts in 2018 with the over 60 billion dollar purchase of the US seed giant Monsanto. Bayer is confronted with numerous other glyphosate lawsuits in the United States, which the company would actually like to settle with a major settlement.
Only three cases have so far been finally negotiated in US courts, and the Dax group lost all three processes. Bayer has not had any success in appointment procedures either. A fourth lawsuit against the group recently began in California.
The Leverkusen-based company has high hopes that one of the judgments by the US Supreme Court will be overturned. In the event that the Supreme Court does not want to deal with the glyphosate case or decides against Bayer, the group recently set up additional provisions of $ 4.5 billion. Bayer had previously set aside more than $ 11 billion for a settlement package to settle US lawsuits.
Jane Stock is a technology author, who has written for 24 Hours World. She writes about the latest in technology news and trends, and is always on the lookout for new and innovative ways to improve his audience’s experience.
